1. Pharmaceutical industry structure and its effect on marketing performance and product innovation -- 2. The environmental forces that influence industry stakeholders and shape their interactions -- 3. Global health care systems and market access : variations on a theme -- 4. The structure of...

The grant of monopoly patent protection is justified normally as a means for giving incentive for innovation. Market driven innovation is not necessarily equitable, however, and the development concerns over the international intellectual property regime governing the products of medical...

People everywhere are struggling to get the medicines they need -- The United States has a drug problem -- Millions of people are dying needlessly -- Cancer patients face particularly deadly barriers to medicines -- The current medicine system neglects many major diseases -- Corporate research...

In his Labor Day address, President Biden stated that the U.S. "has the highest drug prices in the world, and there is no reason for it." For new branded drugs, the first part of that statement is supported by a recent RAND Report (Mulcahy et. al. 2021) which found U.S. average prices are 2.3...